Publication: Exogenous L-Arginine and HDL Can Alter LDL and ox-LDL-Mediated Platelet Activation: Using Platelet P-Selectin Receptor Numbers
dc.contributor.author | ŞENER, AZİZE | |
dc.contributor.authors | Sener, Azize; Enc, Elif; Ozsavci, Derya; Vanizor-Kural, Birgul; Yanikkaya-Demirel, Gulderen; Oba, Rabia; Uras, Fikriye; Demir, Muzaffer | |
dc.date.accessioned | 2022-03-12T18:04:57Z | |
dc.date.available | 2022-03-12T18:04:57Z | |
dc.date.issued | 2011 | |
dc.description.abstract | The aim of this study is to investigate the effects of exogenous L-arginine and HDL on LDL and oxidized LDL (ox-LDL)-mediated platelet activation. Adenosine diphosphate (ADP)-activated platelets have been incubated with lipoproteins with or without L-arginine. P-selectin receptor numbers per platelet have been measured by flow cytometry. After incubation with only L-arginine (without lipoproteins), platelet nitric oxide (NO) levels and P-selectin receptor numbers significantly increased compared to the controls (P < .05). After incubation with LDL or ox-LDL, receptor numbers of P-selectin significantly increased (P < .001). However, P-selectin receptor numbers in platelets treated with L-arginine + LDL or L-arginine + ox-LDL decreased compared to the levels in platelets treated with only LDL or ox-LDL (P < .01, P < .001, respectively). Addition of HDL to L-arginine + ox-LDL caused significant reduction in P-selectin receptor numbers as in the control values (P < .001). We have concluded that L-arginine causes enhanced platelet NO levels and blocks the effects of LDL or ox-LDL on platelet P-selectin receptor numbers and HDL also strengthens this effect of L-arginine. | |
dc.identifier.doi | 10.1177/1076029610385223 | |
dc.identifier.eissn | 1938-2723 | |
dc.identifier.issn | 1076-0296 | |
dc.identifier.pubmed | 21078607 | |
dc.identifier.uri | https://hdl.handle.net/11424/230533 | |
dc.identifier.wos | WOS:000300376400016 | |
dc.language.iso | eng | |
dc.publisher | SAGE PUBLICATIONS INC | |
dc.relation.ispartof | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | nitric oxide | |
dc.subject | low-density lipoprotein | |
dc.subject | high density lipoprotein | |
dc.subject | oxidized low-density lipoprotein | |
dc.subject | platelet | |
dc.subject | L-arginine | |
dc.subject | P-selectin | |
dc.subject | NITRIC-OXIDE SYNTHASE | |
dc.subject | LOW-DENSITY-LIPOPROTEIN | |
dc.subject | OXIDIZED-LDL | |
dc.subject | EXPRESSION | |
dc.subject | RISK | |
dc.subject | ATHEROSCLEROSIS | |
dc.subject | AGGREGATION | |
dc.subject | PARAOXONASE | |
dc.subject | LEUKOCYTE | |
dc.subject | TRANSPORT | |
dc.title | Exogenous L-Arginine and HDL Can Alter LDL and ox-LDL-Mediated Platelet Activation: Using Platelet P-Selectin Receptor Numbers | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | da1c1640-4e63-4a5c-9b70-0f30a2edfb32 | |
local.import.package | SS17 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.indexed.at | PUBMED | |
local.journal.numberofpages | 8 | |
oaire.citation.endPage | E86 | |
oaire.citation.issue | 6 | |
oaire.citation.startPage | E79 | |
oaire.citation.title | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | |
oaire.citation.volume | 17 | |
relation.isAuthorOfPublication | fd65174e-4126-41c3-913d-e8bcdce20632 | |
relation.isAuthorOfPublication.latestForDiscovery | fd65174e-4126-41c3-913d-e8bcdce20632 |